全部 |
  • 全部
  • 题名
  • 作者
  • 机构
  • 关键词
  • NSTL主题词
  • 摘要
检索 二次检索 AI检索
外文文献 中文文献
筛选条件:

1. Alstonia scholaris (L.) R. Br. ameliorated diabetic nephropathy through PPAR-δ pathway NSTL国家科技图书文献中心

Qin, Shi-Shi |  Tian, Cai-Bo... -  《Journal of Ethnopharmacology》 - 2025,348 - 119839~119839 - 共16页

摘要:Ethnopharmacological relevance: Alstonia |  scholaris was utilized as a medicinal herb for the |  management of diabetes traditionally, with diabetic |  nephropathy (DN) was one of its major complications. However | , the effect of A. scholaris on DN have yet to be
关键词: Diabetic nephropathy |  Indole alkaloids |  Alstonia scholaris |  PPAR-delta pathway

2. Chemical constituents of the herb of Thermopsis lanceolata R. Br. and their stimulation of seed germination of Triticum aestivum L NSTL国家科技图书文献中心

Wu, Xing-Ya |  Tan, Jian-Guo... -  《Phytochemistry》 - 2025,236 - 共13页

摘要:To discover novel plant growth regulators |  (PGRs) from natural products, the chemical |  constituents of the herb Thermopsis lanceolata were |  systematically investigated, leading to the isolation of 17 |  quinolizidine alkaloids (QAs) (1-17), 9 sesquiterpenes (18-26
关键词: Thermopsis lanceolata |  Leguminosae |  Quinolizidine alkaloids |  Sesquiterpenes |  Lignans |  Isoflavones |  Seed germination

3. Optimization of callus induction and cell suspension system in Hemidesmus indicus (L.) R. Br. for improved production of lupeol NSTL国家科技图书文献中心

Jayachandran,Halka |  Kumaresan,Kowsalya... -  《Plant Cell, Tissue and Organ Culture》 - 2025,161(2) - 共5页

摘要:Abstract Hemidesmus indicus (L.) R.Br. is an |  ethnopharmacologically important medicinal plant with valuable |  bioactive compounds and industrially important secondary |  metabolites. This plant has a promising role in treating a |  wide spectrum of ailments, such as cancer
关键词: Hemidesmus indicus |  Cell suspension culture system |  Auxins |  MS media strength |  Carbon sources |  Lupeol

4. Receptor-regulated smads (R-Smads) in the liver fluke Fasciola gigantica: Characterization, comparative sequence analysis, and life stage-specific expression NSTL国家科技图书文献中心

Ornampai Japa |  Chorpaka Phuangsri... -  《Acta tropica.》 - 2025,264 - Article 107603~Article 107603 - 共14页

摘要: protein (BMP)-specific R-Smads (BR-Smads) due to their |  (R-Smads) in Fasciola gigantica, a major parasite |  regions. Four R-Smads were identified: FgSmad1/5 |  these R-Smads, isolated using the rapid amplification | /activin-specific R-Smads (AR-Smads), displaying a
关键词: AR-Smad; BR-Smad; Fasciola gigantica; R-Smad; Receptor-regulated Smad; Transforming growth

5. Neoadjuvant Treatment with Changes in Chemotherapy Regimens According to Carbohydrate Antigen 19-9 Level for Resectable/Borderline Resectable Pancreatic Ductal Adenocarcinoma NSTL国家科技图书文献中心

Daisuke,Hashimoto |  Sohei,Satoi... -  《Annals of surgical oncology》 -  MD, PhD |  MD, PhD, FACS |  MD - 2025,32(1) - 517~528 - 共12页

摘要: patients with resectable/borderline resectable (R/BR |  improve the outcome of R/BR-PDAC patients with poor | Abstract Background The response of |  carbohydrate antigen (CA) 19-9 to neoadjuvant therapy (NAT | ) for pancreatic ductal adenocarcinoma (PDAC) may
关键词: Neoadjuvant treatment |  CA19-9 |  Pancreatic ductal adenocarcinoma |  Surgery |  Pancreatectomy

6. In Vitro and In Silico Evaluation of Anticancer Potential and Apoptotic Activity of Benzimidazole-Based Compounds NSTL国家科技图书文献中心

Messaoudi, Sabri |  Alminderej, Fahad M.... -  《Chemistry Select》 - 2025,10(8) - n/a~n/a - 共18页

摘要: the para position, the appropriate bromine radius (r | (Br) = 1.83 & Aring;) for derivative 6b, and the |  hydroxylated group (r(O) = 1.52 & Aring; for oxygen) for | In this study, two series of benzimidazole |  derivatives were evaluated for their anticancer activity
关键词: Anticancer activity |  Apoptosis |  Benzimidazole derivatives |  Cell cycle analysis |  Docking study

7. A classification model for resectability in hepatocellular carcinoma patients NSTL国家科技图书文献中心

Nakamura, Ikuo |  Yoh, Tomoaki... -  《Hepatology research》 - 2025,55(1) - 94~105 - 共12页

摘要: assigned to the non-UR (R and BR classes combined; n | ). Patient characteristics in the BR-HCC and R-HCC groups | , 229 and 56 were classified into the R- and BR-HCC |  classified patients into three categories: resectable (R | ), borderline resectable (BR), and unresectable (UR). Patients
关键词: hepatectomy |  hepatocellular carcinoma |  resectability classification

8. Effect of integrated nutrient management in pearl millet (Pennisetum glaucum)- wheat (Triticum aestivum) system under water saline irrigation NSTL国家科技图书文献中心

Prakash, Ram |  Dhanda, Ankush... -  《The Indian Journal of Agricultural Sciences》 - 2025,95(1) - 95~100 - 共6页

摘要: glaucum (L.) R. Br.]-wheat (Triticum aestivum L | Salinity predominates in the arid and semi | -arid regions which negatively affects the crops yield | , nutrient availability, and microbes present in the soil | . The present study was carried out during 2019-2021
关键词: Integrated nutrient management |  Manures |  Pearl millet |  Salinity |  Soil properties |  Wheat |  Yield

9. Outcome of extra-nodal follicular lymphoma affected by choice of induction chemoimmunotherapy and maintenance rituximab - real-world retrospective study NSTL国家科技图书文献中心

Ng, Lawrence Cheng K... |  Ong, Shin Yeu... -  《Leukemia and lymphoma》 - 2025,66(5/6) - 906~912 - 共7页

摘要: analyzed 143 patients who received either R-CHOP or |  Bendamustine-Rituximab (BR), with a median follow-up of 69.7 |  patients with extra-nodal disease revealed that BR |  induction conferred superior PFS compared to R-CHOP (HR |  R-CHOP without maintenance rituximab had
关键词: follicular lymphoma |  extra-nodal |  R-CHOP |  Bendamustine-Rituximab |  maintenance rituximab

10. Loncastuximab Tesirine Versus Polatuzumab Vedotin Plus Bendamustine and Rituximab in Relapsed/Refractory DLBCL After ≥ 2 Lines of Therapy: Matching-Adjusted Indirect Comparison NSTL国家科技图书文献中心

Wilson, Koo |  Chiodi, Francesca... -  《Advances in therapy.》 - 2025,42(5) - 2445~2464 - 共20页

摘要: with Pola + BR in patients with R/R DLBCL after two |  treatments, relapsed/refractory (R/R) diffuse large B-cell |  for patients with third-line R/R DLBCL. Methods: In |  rituximab (Pola + BR). Results: Four studies included in |  three comparator studies for Pola + BR (GO29365
关键词: Antibody-drug conjugates |  Comparative efficacy |  Diffuse large B-cell lymphoma |  Loncastuximab tesirine |  Matching-adjusted indirect comparison |  Polatuzumab vedotin plus bendamustine and rituximab |  Relapsed/refractory |  Response rate
检索条件R. BR.
  • 检索词扩展

NSTL主题词

  • NSTL学科导航